EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study

Jérôme Doyen iD, Alexandre Lacour, Renaud Schiappa, Eva Seutin, Amanda Garrido, Tanguy Pace Loscos, Denis Doyen

JNCI Cancer Spectrum · 2026

DOI: 10.1093/jncics/pkag110 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JNCI Cancer Spectrum, 2026. Verfasst von Jérôme Doyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Antoine Lacassagne Cancer Center, Côte d'Azur University, Nice, France. Hauptthemen laut MEDLINE: Neoplasms, COVID-19, Thrombosis. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 has been associated with an increased thrombotic risk, potentially exacerbated in patients with active cancer. We conducted a retrospective cohort study including 119 cancer patients with COVID-19 and 214 matched pre-pandemic controls. Patients with COVID-19 had poorer performance status and were more frequently treated with palliative intent. After a median follow-up of 32.7 months, overall thrombotic event rates did not differ between groups. However, after adjustment for clinically relevant covariates and accounting for death as a competing event, COVID-19 status and palliative treatment intent remained independently associated with a higher cumulative incidence of thrombotic events. In conclusion, COVID-19 may increase thrombotic risk in patients with cancer and occurs more frequently in patients with poorer clinical status. These findings are exploratory and require confirmation in larger prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCOVID-19ThrombosisHumansFemaleRetrospective StudiesMaleMiddle AgedAgedRisk FactorsPalliative CareIncidenceSARS-CoV-2Case-Control Studies

Autor:innen und Institutionen

  • Department of Radiation Oncology, Antoine Lacassagne Cancer Center, Côte d'Azur University, Nice, France.
  • Department of Gastroenterology, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Department of Epidemiology, Biostatistics and Health Data, Centre Antoine-Lacassagne, Côte d'Azur University, Nice, France.
  • ICBMS-Institut de Chimie et de Biochimie Moléculaires et Supramoléculaires, Equipe COSSBA UMR 5246, Lyon, France.
  • Unité d'Explorations Fonctionnelles, Centre Hospitalier Universitaire de Nice, Côte d'Azur University, Nice, France.
  • LP2M, Laboratoire de Physiomédecine Moléculaire, CNRS, Côte d'Azur University, Nice, France.

ORCID-Profile: Jérôme Doyen

Zitieren

APA

Doyen, J., Lacour, A., Schiappa, R., Seutin, E., Garrido, A., Loscos, T. P., & Doyen, D. (2026). COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkag110

Vancouver

Doyen J, Lacour A, Schiappa R, Seutin E, Garrido A, Loscos TP, et al. COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study. JNCI Cancer Spectrum. 2026. doi:10.1093/jncics/pkag110

BibTeX
@article{Doyen2026,
  author = {Doyen, Jérôme and Lacour, Alexandre and Schiappa, Renaud and Seutin, Eva and Garrido, Amanda and Loscos, Tanguy Pace and Doyen, Denis},
  title = {COVID-19 and thrombotic risk in patients with active cancer: a matched cohort study},
  journal = {JNCI Cancer Spectrum},
  year = {2026},
  doi = {10.1093/jncics/pkag110}
}
Kostenlos starten →